Metformin enhances LDL-cholesterol uptake by suppressing the expression of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) in liver cells
Author:
Funder
university of sharjah
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-022-03022-x.pdf
Reference64 articles.
1. G. Rena, D.G. Hardie, E.R. Pearson, The mechanisms of action of metformin. Diabetologia 60, 1577–1585 (2017)
2. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, F. Andreelli, Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. (Lond.) 122(6), 253–270 (2012). https://doi.org/10.1042/CS20110386
3. F. Luo, A. Das, J. Chen, P. Wu, X. Li, Z. Fang, Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management. Cardiovasc Diabetol. 18, 54 (2019). https://doi.org/10.1186/s12933-019-0860-y
4. S.R. Salpeter, N.S. Buckley, J.A. Kahn, E.E. Salpeter, Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am. J. Med 121, 149–57e2 (2008). https://doi.org/10.1016/j.amjmed.2007.09.016
5. R. Ladeiras-Lopes, R. Fontes-Carvalho, N. Bettencourt, F. Sampaio, V. Gama, A. Leite-Moreira, Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease. Expert Opin. Ther. Targets 19(7), 869–877 (2015). https://doi.org/10.1517/14728222.2015.1025051
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genetic landscape of anin vivoprotein interactome;2023-12-15
2. The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9;Heliyon;2023-09
3. Chrysin 7‐O‐β‐d‐glucopyranoside increases hepatic low‐density lipoprotein receptor expression through AMP‐activated protein kinase activation;FEBS Open Bio;2023-07-03
4. Insight into the role of PCSK9 in glucose metabolism;Clinica Chimica Acta;2023-07
5. PCSK9 Inhibitors as Adjunctive Therapies in Hypercholesterolemia: Benefits, Limitations, and Possible Alternatives;Advanced Therapeutics;2023-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3